These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23306612)

  • 1. Inhibition of FOXM1 transcription factor suppresses cell proliferation and tumor growth of breast cancer.
    Yang C; Chen H; Yu L; Shan L; Xie L; Hu J; Chen T; Tan Y
    Cancer Gene Ther; 2013 Feb; 20(2):117-24. PubMed ID: 23306612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated RNA interference targeting FOXM1 transcription factor suppresses cell proliferation and tumor growth of nasopharyngeal carcinoma.
    Chen H; Yang C; Yu L; Xie L; Hu J; Zeng L; Tan Y
    J Gene Med; 2012 Apr; 14(4):231-40. PubMed ID: 22359343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of FOXM1 transcription factor expression by adenovirus-mediated RNA interference inhibits human hepatocellular carcinoma growth.
    Chen T; Xiong J; Yang C; Shan L; Tan G; Yu L; Tan Y
    Cancer Gene Ther; 2014 Mar; 21(3):133-8. PubMed ID: 24577129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
    Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
    Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors.
    Ahmad A; Wang Z; Kong D; Ali S; Li Y; Banerjee S; Ali R; Sarkar FH
    Breast Cancer Res Treat; 2010 Jul; 122(2):337-46. PubMed ID: 19813088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
    Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
    Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FOXM1 (Forkhead box M1) in tumorigenesis: overexpression in human cancer, implication in tumorigenesis, oncogenic functions, tumor-suppressive properties, and target of anticancer therapy.
    Wierstra I
    Adv Cancer Res; 2013; 119():191-419. PubMed ID: 23870513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
    Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
    Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The suppression of FOXM1 and its targets in breast cancer xenograft tumors by siRNA.
    Wang M; Gartel AL
    Oncotarget; 2011 Dec; 2(12):1218-26. PubMed ID: 22203467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1 cistrome predicts breast cancer metastatic outcome better than FOXM1 expression levels or tumor proliferation index.
    Yau C; Meyer L; Benz S; Vaske C; Scott G; Egan B; Labhart P; Pourmand N; Benz CC
    Breast Cancer Res Treat; 2015 Nov; 154(1):23-32. PubMed ID: 26456572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.
    Yang C; Chen H; Tan G; Gao W; Cheng L; Jiang X; Yu L; Tan Y
    Cancer Lett; 2013 Oct; 340(1):104-12. PubMed ID: 23856032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression.
    Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW
    Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,3'-Diindolylmethane enhances taxotere-induced growth inhibition of breast cancer cells through downregulation of FoxM1.
    Ahmad A; Ali S; Wang Z; Ali AS; Sethi S; Sakr WA; Raz A; Rahman KM
    Int J Cancer; 2011 Oct; 129(7):1781-91. PubMed ID: 21154750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The forkhead box M1 transcription factor contributes to the development and growth of mouse colorectal cancer.
    Yoshida Y; Wang IC; Yoder HM; Davidson NO; Costa RH
    Gastroenterology; 2007 Apr; 132(4):1420-31. PubMed ID: 17408638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer.
    Kim IM; Ackerson T; Ramakrishna S; Tretiakova M; Wang IC; Kalin TV; Major ML; Gusarova GA; Yoder HM; Costa RH; Kalinichenko VV
    Cancer Res; 2006 Feb; 66(4):2153-61. PubMed ID: 16489016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
    Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
    Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant overexpression of FOXM1 transcription factor plays a critical role in lung carcinogenesis induced by low doses of arsenic.
    Liu Y; Hock JM; Van Beneden RJ; Li X
    Mol Carcinog; 2014 May; 53(5):380-91. PubMed ID: 23255470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative proteomic analysis identifies new effectors of FOXM1 involved in breast cancer cell migration.
    Ye X; Zhang Y; He B; Meng Y; Li Y; Gao Y
    Int J Clin Exp Pathol; 2015; 8(12):15836-44. PubMed ID: 26884854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-802 suppresses breast cancer proliferation through downregulation of FoxM1.
    Yuan F; Wang W
    Mol Med Rep; 2015 Sep; 12(3):4647-4651. PubMed ID: 26080894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in breast cancer.
    McGovern UB; Francis RE; Peck B; Guest SK; Wang J; Myatt SS; Krol J; Kwok JM; Polychronis A; Coombes RC; Lam EW
    Mol Cancer Ther; 2009 Mar; 8(3):582-91. PubMed ID: 19276163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.